It is important to highlight that both SOX2 (P ≤ 0.01), and GLI‐1 (P ≤ 0.05) genes remain significantly overexpressed in both non‐ and risk‐exposed lung cancer patient subgroups (Fig. 5A,B). This evidence concerns the gene SOX2 and lung carcinoma.